During the past decade, North Georgia Heart Foundation conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Georgia Heart Foundation" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "Aziyo Biologics, Inc." with 1 trials sponsored, "Biosensors Europe SA" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Corindus Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Georgia Heart Foundation" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "OrbusNeich Medical K.K." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "North Georgia Heart Foundation" are "Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials), "Arterial Occlusive Diseases" (1 trials), "Arteriosclerosis" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "North Georgia Heart Foundation" in a lesser frequency.

Most popular intervention types in "North Georgia Heart Foundation" are "Device" (4 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antiplatelet Drug" (1 trials), "BioFreedom™ Drug Coated Coronary Stent System" (1 trials), "CorPath-assisted Percutaneous Coronary Intervention" (1 trials), "Everolimus Eluting Stent (EES)" (1 trials) and "OrbusNeich Combo stent™" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Georgia Heart Foundation" are 7 trials for "All" genders.

Currently, there are NaN active trials in "North Georgia Heart Foundation". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in North Georgia Heart Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in North Georgia Heart Foundation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".